Fermentation Driven APIs and Biopharmaceutical Manufacturing

Fermentation Driven Active Pharmaceutical Ingredients & Biopharmaceutical Manufacturing.

GTBL leverages its deep fermentation heritage and leadership in Rifamycin to develop complex molecules for the global pharmaceutical value chain. Evolving from pharmaceutical intermediates into an integrated API platform with CDMO capabilities, we support both biological and synthetic modalities at commercial scale.

Since

0
Fermentation Volume

0KL
Hybrid Power

0MW

Fermentation

Fermentation is at the core of GTBL’s manufacturing capabilities. Our Vapi facility houses fully integrated, technology-driven fermentation operations - from precision-controlled seed and inoculum development through large-scale production fermentation to advanced downstream recovery and purification. Automated process control, real-time monitoring, and optimized strain and media systems ensure consistent, high-purity output batch after batch, while green-chemistry-driven processing keeps yields high and environmental impact low — reflecting GTBL's position at the technological forefront of fermentation-based API manufacturing in India.
Integrated API Platform

Driven by advanced process chemistry and rigorous impurity control, we provide global pharmaceutical partners with a reliable supply of high-purity molecules.
Integrated CDMO Services

We provide end-to-end contract development and manufacturing solutions spanning microbial fermentation and synthetic biology platforms.

We accelerate clinical-scale development and scale-up, from early-stage pilot optimization through to commercial-scale, multi-ton manufacturing.

Our Business Partners